Greenwich LifeSciences Statistics
Total Valuation
GLSI has a market cap or net worth of $127.05 million. The enterprise value is $128.52 million.
Important Dates
The next estimated earnings date is Monday, May 19, 2025, after market close.
Earnings Date | May 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GLSI has 13.14 million shares outstanding. The number of shares has increased by 1.49% in one year.
Current Share Class | 13.14M |
Shares Outstanding | 13.14M |
Shares Change (YoY) | +1.49% |
Shares Change (QoQ) | +1.83% |
Owned by Insiders (%) | 55.06% |
Owned by Institutions (%) | 9.69% |
Float | 5.91M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 26.96 |
P/TBV Ratio | 26.98 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.91
Current Ratio | 6.91 |
Quick Ratio | 6.91 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -151.72% and return on invested capital (ROIC) is -97.25%.
Return on Equity (ROE) | -151.72% |
Return on Assets (ROA) | -89.85% |
Return on Invested Capital (ROIC) | -97.25% |
Return on Capital Employed (ROCE) | -216.02% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.50M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.60% in the last 52 weeks. The beta is 3.32, so GLSI's price volatility has been higher than the market average.
Beta (5Y) | 3.32 |
52-Week Price Change | -50.60% |
50-Day Moving Average | 12.03 |
200-Day Moving Average | 13.62 |
Relative Strength Index (RSI) | 26.33 |
Average Volume (20 Days) | 33,420 |
Short Selling Information
The latest short interest is 658,402, so 5.01% of the outstanding shares have been sold short.
Short Interest | 658,402 |
Short Previous Month | 643,502 |
Short % of Shares Out | 5.01% |
Short % of Float | 11.15% |
Short Ratio (days to cover) | 35.18 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -10.76M |
Pretax Income | -9.24M |
Net Income | -10.50M |
EBITDA | -10.76M |
EBIT | -10.76M |
Earnings Per Share (EPS) | -$0.81 |
Full Income Statement Balance Sheet
The company has $5.82 million in cash and n/a in debt, giving a net cash position of $5.82 million or $0.44 per share.
Cash & Cash Equivalents | 5.82M |
Total Debt | n/a |
Net Cash | 5.82M |
Net Cash Per Share | $0.44 |
Equity (Book Value) | 4.98M |
Book Value Per Share | 0.38 |
Working Capital | 4.98M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -7.57M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |